These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3]. Nakai H, Maekawa N, Nakanishi M, Kawai M, Naito M. Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481 [No Abstract] [Full Text] [Related]
4. [Possibility of the intensification of tuberculosis chemotherapy and its limits]. Naito M, Kanai K, Kondo E, Yamashita H, Matsui K. Kekkaku; 1969 Nov; 44(11):377-93. PubMed ID: 4982567 [No Abstract] [Full Text] [Related]
7. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis]. Firsova VA, Rusakova LI, Grigor'eva ZP, Ryzhova AP, Iatskova TV, Poluéktova FG. Probl Tuberk; 2001 Nov; (1):28-30. PubMed ID: 11337776 [Abstract] [Full Text] [Related]
8. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability]. Koretskaia NM, Iarygina IV. Probl Tuberk Bolezn Legk; 2007 Nov; (2):17-20. PubMed ID: 17419328 [Abstract] [Full Text] [Related]
9. [Value of the bacteriological study of the associated bacterial flora of the sputum of patients with chronic pulmonary tuberculosis]. Boccitto G, Salvati F, De Ritis G. Policlinico Prat; 1970 Apr 13; 77(15):477-89. PubMed ID: 4987995 [No Abstract] [Full Text] [Related]
10. Pulmonary disease due to Mycobacterium massiliense. Mitra S, Tapadar SR, Banerjee D, Bhattacharjee S, Dey S, Kundu S. Indian J Chest Dis Allied Sci; 2012 Apr 13; 54(1):53-7. PubMed ID: 22779125 [Abstract] [Full Text] [Related]
11. [Evaluation of BK positivity and resistance of Mycobacterium tuberculosis 1983-1986 in areas of Bosnia and Herzegovina]. Vinik LK, Konjicija A, Sutić N, Psorn-Rajs A, Matić M, Arslanagić N. Plucne Bolesti; 1988 Apr 13; 40(1-2):32-5. PubMed ID: 3141940 [No Abstract] [Full Text] [Related]
12. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears. Diacon AH, Patientia RF, Venter A, van Helden PD, Smith PJ, McIlleron H, Maritz JS, Donald PR. Antimicrob Agents Chemother; 2007 Aug 13; 51(8):2994-6. PubMed ID: 17517849 [Abstract] [Full Text] [Related]
14. [Isolation of atypical Mycobacteria from the patients with tuberculosis and methods of their primary identification]. Mikhaĭlova LV. Sov Zdravookhr Kirg; 1973 Aug 13; 4():53-5. PubMed ID: 4207845 [No Abstract] [Full Text] [Related]
16. [The rate of destruction of sensitive mycobacteria as a factor in the development of resistance in cavitating pulmonary tuberculosis]. Seri I. Prax Pneumol; 1974 May 13; 28(5):256-62. PubMed ID: 4210051 [No Abstract] [Full Text] [Related]
17. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients]. Kameda K, Kudo S, Iwai K, Ushikubo K. Kekkaku; 1970 Sep 13; 45(9):283-7. PubMed ID: 4989932 [No Abstract] [Full Text] [Related]
18. Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease. Mitchison DA. Soc Appl Bacteriol Symp Ser; 1996 Sep 13; 25():72S-80S. PubMed ID: 8972122 [No Abstract] [Full Text] [Related]